Across the world, hundreds of thousands of people suffer from retinal degenerative diseases, including macular degeneration and retinitis pigmentosa.    These ailments result in significant or even total vision loss, radically affecting day-to-day life.    NanoRetina, with the help of SCHOTT Primoceler, has taken a major step towards changing this situation by developing an entirely new, less invasive, and high performing retinal implant with the first human trials successfully taking pl...